OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) have been given a consensus rating of “Moderate Buy” by the eleven research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $24.4444.

Several brokerages have issued reports on KIDS. BTIG Research restated a “buy” rating and issued a $24.00 target price on shares of OrthoPediatrics in a report on Friday, May 1st. Canaccord Genuity Group set a $25.00 price target on OrthoPediatrics in a report on Friday, April 24th. TD Cowen reissued a “buy” rating on shares of OrthoPediatrics in a research report on Monday, June 15th. Weiss Ratings reissued a “sell (e+)” rating on shares of OrthoPediatrics in a report on Tuesday, April 21st. Finally, Truist Financial set a $17.00 price objective on shares of OrthoPediatrics in a report on Friday, May 1st.

Institutional Trading of OrthoPediatrics

Hedge funds have recently made changes to their positions in the company. Millennium Management LLC increased its holdings in shares of OrthoPediatrics by 48.0% during the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock worth $24,802,000 after buying an additional 452,840 shares during the last quarter. Prosight Management LP lifted its holdings in OrthoPediatrics by 319.2% in the third quarter. Prosight Management LP now owns 308,707 shares of the company’s stock valued at $5,720,000 after acquiring an additional 235,060 shares during the last quarter. Granahan Investment Management LLC grew its position in OrthoPediatrics by 35.1% in the first quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after acquiring an additional 232,760 shares during the period. Wasatch Advisors LP grew its position in OrthoPediatrics by 56.6% in the second quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after acquiring an additional 186,357 shares during the period. Finally, Deerfield Management Company L.P. grew its position in OrthoPediatrics by 1,153.4% in the third quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock worth $3,597,000 after acquiring an additional 178,623 shares during the period. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Trading Up 1.9%

KIDS opened at $20.72 on Tuesday. The firm has a market capitalization of $532.09 million, a price-to-earnings ratio of -12.33 and a beta of 0.99. The company’s 50 day simple moving average is $18.48 and its two-hundred day simple moving average is $17.64. OrthoPediatrics has a 1-year low of $14.42 and a 1-year high of $23.70. The company has a debt-to-equity ratio of 0.29, a current ratio of 5.21 and a quick ratio of 2.37.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Thursday, April 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.04. OrthoPediatrics had a negative return on equity of 7.01% and a negative net margin of 16.31%.The business had revenue of $59.36 million during the quarter, compared to analyst estimates of $58.28 million. Analysts expect that OrthoPediatrics will post -1.13 EPS for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.